Harrow Health Stock Net Income
| HROW Stock | USD 10.27 0.05 0.48% |
Harrow Health fundamentals help investors to digest information that contributes to Harrow Health's financial success or failures. It also enables traders to predict the movement of Harrow Stock. The fundamental analysis module provides a way to measure Harrow Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harrow Health stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -24.4 M | -23.2 M | |
| Net Loss | -24.4 M | -23.2 M | |
| Net Loss | -12.7 M | -12 M | |
| Net Loss | (0.75) | (0.79) | |
| Net Income Per E B T | 1.02 | 0.97 |
Harrow | Net Income |
Harrow Health Company Net Income Analysis
Harrow Health's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Harrow Health Net Income | (24.41 M) |
Most of Harrow Health's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harrow Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Harrow Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Harrow Health is extremely important. It helps to project a fair market value of Harrow Stock properly, considering its historical fundamentals such as Net Income. Since Harrow Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Harrow Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Harrow Health's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Harrow Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Harrow Health reported net income of (24.41 Million). This is 107.15% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 104.28% higher than that of the company.
Harrow Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Harrow Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Harrow Health could also be used in its relative valuation, which is a method of valuing Harrow Health by comparing valuation metrics of similar companies.Harrow Health is currently under evaluation in net income category among related companies.
Harrow Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Harrow Health from analyzing Harrow Health's financial statements. These drivers represent accounts that assess Harrow Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Harrow Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 197.0M | 177.6M | 231.2M | 405.3M | 365.3M | 383.6M | |
| Enterprise Value | 213.3M | 197.1M | 267.0M | 413.2M | 481.7M | 505.8M |
Harrow Health Institutional Holders
Institutional Holdings refers to the ownership stake in Harrow Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Harrow Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Harrow Health's value.| Shares | Stifel Financial Corp | 2023-12-31 | 432 K | Citadel Advisors Llc | 2023-09-30 | 330.9 K | Northern Trust Corp | 2023-12-31 | 316.8 K | Wasatch Advisors Lp | 2023-12-31 | 302.5 K | Royce & Associates, Lp | 2023-12-31 | 294.9 K | Franklin Resources Inc | 2023-12-31 | 294.2 K | Rice Hall James & Associates, Llc | 2023-12-31 | 231.5 K | Nuveen Asset Management, Llc | 2023-12-31 | 221.8 K | Westside Investment Management, Inc. | 2023-12-31 | 212.3 K | Opaleye Management Inc | 2023-12-31 | 3.8 M | Private Capital Management, Llc | 2023-12-31 | 2.8 M |
Harrow Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | 0.0022 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 470.57 M | ||||
| Shares Outstanding | 35.36 M | ||||
| Shares Owned By Insiders | 14.58 % | ||||
| Shares Owned By Institutions | 66.68 % | ||||
| Number Of Shares Shorted | 6.12 M | ||||
| Price To Earning | 24.45 X | ||||
| Price To Book | 6.33 X | ||||
| Price To Sales | 3.44 X | ||||
| Revenue | 130.19 M | ||||
| Gross Profit | 63.21 M | ||||
| EBITDA | 12.92 M | ||||
| Net Income | (24.41 M) | ||||
| Cash And Equivalents | 51.7 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 190.5 M | ||||
| Current Ratio | 5.01 X | ||||
| Book Value Per Share | 2.01 X | ||||
| Cash Flow From Operations | 3.84 M | ||||
| Short Ratio | 10.56 X | ||||
| Earnings Per Share | (0.75) X | ||||
| Price To Earnings To Growth | (2.50) X | ||||
| Target Price | 25.65 | ||||
| Number Of Employees | 315 | ||||
| Beta | 0.5 | ||||
| Market Capitalization | 364.94 M | ||||
| Total Asset | 311.75 M | ||||
| Retained Earnings | (133.9 M) | ||||
| Working Capital | 90.14 M | ||||
| Current Asset | 8.77 M | ||||
| Current Liabilities | 2.56 M | ||||
| Net Asset | 311.75 M |
About Harrow Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Harrow Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harrow Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harrow Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Harrow Health Piotroski F Score and Harrow Health Altman Z Score analysis. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Harrow Stock analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Harrow Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share (0.75) | Revenue Per Share 3.992 | Quarterly Revenue Growth 0.788 | Return On Assets 0.0022 |
The market value of Harrow Health is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.